Neuroendocrine Tumors and Pregnancy: The French PregNET Study

Key Points

• Evaluate the safety of pregnancy in women with neuroendocrine tumors and the role of somatostatin analogs.
• Conducted in France with a focus on women diagnosed with NETs during pregnancy.
• Utilized a multidisciplinary approach for managing care during and after pregnancy.
• Included postpartum tumor assessment for optimizing outcomes.
• No major safety concerns associated with somatostatin analogs during pregnancy were found.
• Recommendations suggest individualized treatment and careful monitoring of patients in this context.

Abstract